Иммунотерапия: открытый доступ | 9

Yao Zhang, Ling Li, Yakun Li, Zengmin Yang, Aijing Zhang, Ercui Shen, Yun Liu, Yan Wang, Minghui Zheng, Xiao Chen, Shuming Wu, Haijiang Zhang, Yongjiang Liu

Поделитесь этой статьей

исследовательская статья

Development and Characterization of Neutralizing Antibodies against SARS-CoV-2

Yao Zhang, Ling Li, Yakun Li, Zengmin Yang, Aijing Zhang, Ercui Shen, Yun Liu, Yan Wang, Minghui Zheng, Xiao Chen, Shuming Wu, Haijiang Zhang, Yongjiang Liu

Поделитесь этой статьей

Иммунотерапия: открытый доступ
Открытый доступ

Объем 9, Проблема 3 (2023)

Lung Cancer Immunotherapy: Its Advancements and Challenges

Lung Cancer Immunotherapy: Its Advancements and Challenges

Lung Cancer Immunotherapy: Its Advancements and Challenges

Differential Expression Analysis of Natural Killer (NK) Cell Receptor (NKG2D) in Hepatitis C Virus-Infected Chronic Hepatitis and Hepatocellular Patients for the Development of Targeted Immunotherapy

Differential Expression Analysis of Natural Killer (NK) Cell Receptor (NKG2D) in Hepatitis C Virus-Infected Chronic Hepatitis and Hepatocellular Patients for the Development of Targeted Immunotherapy

Differential Expression Analysis of Natural Killer (NK) Cell Receptor (NKG2D) in Hepatitis C Virus-Infected Chronic Hepatitis and Hepatocellular Patients for the Development of Targeted Immunotherapy

Cancer Immunotherapy: Its Types, Applications and Challenges

Colon Cancer: Its Symptoms, Diagnosis, Treatment and Prevention

Benefits of Allergen Immunotherapy and Safety Considerations

Cancer Immunotherapy: Its Types, Applications and Challenges

Colon Cancer: Its Symptoms, Diagnosis, Treatment and Prevention

Benefits of Allergen Immunotherapy and Safety Considerations

Development and Characterization of Neutralizing Antibodies against SARS-CoV-2

Development and Characterization of Neutralizing Antibodies against SARS-CoV-2

Иммунотерапия: открытый доступОткрытый доступ

Объем 9, Проблема 3 (2023)

Иммунотерапия: открытый доступ
Открытый доступ